|
87
|
274
|
4dflA |
Crystal structure of spleen tyrosine kinase complexed with a sulfonamidopyrazine piperidine inhibitor |
|
81
|
271
|
4c7tA |
Focal adhesion kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor |
|
87
|
309
|
4c8bA |
Structure of the kinase domain of human ripk2 in complex with ponatinib |
|
83
|
261
|
4c3fA |
Structure of lck in complex with a compound discovered by virtual fragment linking |
|
89
|
287
|
4c61A |
Inhibitors of jak2 kinase domain |
|
81
|
272
|
4brxA |
Focal adhesion kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor |
|
89
|
287
|
4c62A |
Inhibitors of jak2 kinase domain |
|
104
|
333
|
4bkzA |
Crystal structure of unphosphorylated maternal embryonic leucine zipper kinase (melk) in complex with a benzodipyrazole inhibitor |
|
96
|
291
|
4aqcA |
Triazolopyridine-based inhibitor of janus kinase 2 |
|
91
|
288
|
4bbfA |
Aminoalkylpyrimidine inhibitor complexes with jak2 |
|
102
|
332
|
4bl1A |
Crystal structure of unphosphorylated maternal embryonic leucine zipper kinase (melk) in complex with amp-pnp |
|
83
|
288
|
4bbeA |
Aminoalkylpyrimidine inhibitor complexes with jak2 |
|
95
|
330
|
4bfmA |
The crystal structure of mouse pk38 |
|
106
|
331
|
4bkyA |
Crystal structure of unphosphorylated maternal embryonic leucine zipper kinase (melk) in complex with pyrrolopyrazole inhibitor |
|
78
|
277
|
4agwA |
Discovery of a small molecule type ii inhibitor of wild-type and gatekeeper mutants of bcr-abl, pdgfralpha, kit, and src kinases |
|
86
|
294
|
3zonA |
Human tyk2 pseudokinase domain bound to a kinase inhibitor |
|
88
|
287
|
3zmmA |
Inhibitors of jak2 kinase domain |
|
93
|
287
|
3zc6A |
Crystal structure of jak3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor |
|
89
|
368
|
3zdtA |
Crystal structure of basic patch mutant fak ferm domain fak31- 405 k216a, k218a, r221a, k222a |
|
84
|
285
|
3zepA |
Crystal structure of jak3 kinase domain in complex with a pyrrolopyrazine-2-phenyl ether inhibitor |
|
117
|
447
|
3vs6A |
Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl}carbamate |
|
116
|
447
|
3vs2A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
117
|
447
|
3vrzA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea |
|
116
|
447
|
3vs5A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
122
|
447
|
3vryA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane |
|
110
|
447
|
3vs4A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2h-pyran-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
123
|
447
|
3vs3A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
106
|
447
|
3vs7A |
Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1h-pyrrolo[2,3-b]pyridin-5-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine |
|
109
|
447
|
3vs0A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor n-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide |
|
112
|
447
|
3vs1A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea |
|
27
|
114
|
3uyoA |
Crystal structure of monobody sh13/abl1 sh2 domain complex |
|
79
|
272
|
3vf9A |
Crystal structure of spleen tyrosine kinase syk catalytic domain with thienopyrazolylindole inhibitor 027 |
|
70
|
264
|
3v8tA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 477 |
|
84
|
273
|
3vf8A |
Crystal structure of spleen tyrosine kinase syk catalytic domain with pyrazolylbenzimidazole inhibitor 416 |
|
21
|
97
|
3us4A |
Crystal structure of a sh2 domain of a megakaryocyte-associated tyrosine kinase (matk) from homo sapiens at 1.50 a resolution |
|
75
|
262
|
3v5lA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 542 |
|
66
|
264
|
3v5jA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 090 |
|
65
|
265
|
3v8wA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 469 |
|
79
|
270
|
3ue4A |
Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the abl tyrosine kinase domain |
|
10
|
65
|
3ueyA |
Structural and functional characterization of an anesthetic binding site in the second cysteine-rich domain of protein kinase cdelta |
|
11
|
65
|
3uglA |
Structural and functional characterization of an anesthetic binding site in the second cysteine-rich domain of protein kinase c delta |
|
85
|
276
|
3uqgA |
C-src kinase domain in complex with bumpless bki analog uw1243 |
|
10
|
65
|
3uejA |
Structural and functional characterization of an anesthetic binding site in the second cysteine-rich domain of protein kinase cdelta |
|
11
|
65
|
3ugiA |
Structural and functional characterization of an anesthetic binding site in the second cysteine-rich domain of protein kinase c delta |
|
95
|
287
|
3ugcA |
Structural basis of jak2 inhibition by the type ii inhibtor nvp-bbt594 |
|
39
|
160
|
3uf4A |
Crystal structure of a sh3 and sh2 domains of fyn protein (proto-concogene tyrosine-protein kinase fyn) from mus musculus at 1.98 a resolution |
|
59
|
288
|
3uiuA |
Crystal structure of apo-pkr kinase domain |
|
12
|
63
|
3ua7A |
Crystal structure of the human fyn sh3 domain in complex with a peptide from the hepatitis c virus ns5a-protein |
|
10
|
65
|
3ugdA |
Structural and functional characterization of an anesthetic binding site in the second cysteine-rich domain of protein kinase c delta |
|
13
|
57
|
3ua6A |
Crystal structure of the human fyn sh3 domain |
